EMEA-000496-PIP01-08-M07
Key facts
Invented name |
Vipidia
|
Active substance |
alogliptin
|
Therapeutic area |
Endocrinology, -gynacology-fertility-metabolism
|
Decision number |
P/0078/2020
|
PIP number |
EMEA-000496-PIP01-08-M07
|
Pharmaceutical form(s) |
Film-coated tablet
|
Condition(s) / indication(s) |
Treatment of type II diabetes mellitus
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Takeda Development Centre Europe Ltd
Tel. +44 20331168000 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|